Halozyme Therapeutics Inc. is a Healthcare company listed on NASDAQ. This page provides financial highlights, valuation notes and related stock research for global investors.
| Price | $69.62 |
| Market Cap | $8.26B |
| P/E Ratio | 24.43 |
| EPS | 2.85 |
| Dividend Yield | N/A |
| 52 Week High | $82.22 |
| 52 Week Low | $51.06 |
Discover Japanese market themes, sector rotation, AI signals and stock dashboards for overseas investors.
Try INST_FLOW GlobalGenerated by INST_FLOW Global. Last updated: 2026-06-24